US Stock MarketDetailed Quotes

SYRS Syros Pharmaceuticals

Watchlist
  • 5.0100
  • +0.0100+0.20%
Close May 9 16:00 ET
133.91MMarket Cap-862P/E (TTM)

Syros Pharmaceuticals Key Stats

Syros Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 14, 2024

Revenue(YoY)

720.00K

-75.63%
EPS(YoY)

-0.87

-2.35%

Strong Buy

Apr 30, 2024

Syros Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 720.000K--
May 14, 20242024/Q1-- / 720.000K--
Mar 27, 20242023/Q4386.000K / 2.000M--
Nov 14, 20232023/Q33.762M / 3.940M--
Aug 8, 20232023/Q22.833M / 3.500M--
May 10, 20232023/Q12.954M / 3.300M--
Mar 2, 20232022/Q4-754.000K / 3.850M--
Nov 14, 20222022/Q33.891M / 4.850M--
Aug 9, 20222022/Q26.276M / 4.783M--
May 16, 20222022/Q15.467M / 4.920M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 720.000K--
May 14, 20242024/Q1-- / 720.000K--
Mar 27, 20242023/Q4386.000K / 2.000M--
Nov 14, 20232023/Q33.762M / 3.940M--
Aug 8, 20232023/Q22.833M / 3.500M--
May 10, 20232023/Q12.954M / 3.300M--
Mar 2, 20232022/Q4-754.000K / 3.850M--
Nov 14, 20222022/Q33.891M / 4.850M--
Aug 9, 20222022/Q26.276M / 4.783M--
May 16, 20222022/Q15.467M / 4.920M--

Unlock Free Earnings Estimates

Syros Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 30, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg